foxc1a and foxc1b promote angiogenesis from veins and suppress angiogenesis from arteries by promoting competing pro-angiogenic Vascular Endothelial Growth Factor signalling, and anti-angiogenic Dll4/Notch signalling in zebrafish embryos.
Introduction
The cardiovascular system is the first functional organ system to form during vertebrate embryogenesis and is essential to facilitate growth and development. Within the cardiovascular system, blood vessels represent the primary conduit for nutrient transport and metabolic exchange and these are formed from endothelial progenitor cells, or angioblasts, which are first specified within the lateral plate mesoderm. During somitogenesis, angioblasts differentiate into arterial and venous cell fates and undergo medial migration to coalesce into a solid linear mass of cells or vascular cord. These vascular cords undergo subsequent lumenisation and are remodelled into a functional and complex vascular network by a process of selective cell sprouting termed angiogenesis. Angiogenesis requires complex co-ordination of cell signalling and cellular behaviours to generate a branched vascular morphology capable of maximising surface area for metabolic exchange while minimising transport distances.
While angiogenesis is tightly regulated by interactions between pro-angiogenic Vascular
Endothelial Growth Factor (VEGF) and anti-angiogenic Notch signalling, reviewed in (Blanco and Gerhardt, 2013) , how these pathways are transcriptionally regulated is not fully understood.
VEGF is a morphogen which signals via distinct ligands to induce migratory behaviour within endothelial cells (ECs) and drive blood vessel sprouting. In zebrafish, angiogenesis from arteries is promoted primarily by interaction of Vegfa with its cognate receptor Vegfr4/Kdrl or Vegfr2/Kdr (Bahary et al., 2007; Covassin et al., 2006; Habeck et al., 2002; Nasevicius et al., 2000) , whereas Vegfc promotes sprouting from veins via Vegfr3/Flt4 (Hogan et al., 2009b; Le Guen et al., 2014; Villefranc et al., 2013) . Within an angiogenic sprout, leading ECs are termed tip cells and these are followed by trailing stalk cells. As an angiogenic sprout forms, a migrating EC extends filopodia to sense VEGF signals and upregulate Dll4 transcription (Gerhardt et al., 2003; Hellstrom et al., 2007) , inducing Notch signalling in neighbouring cells and this acts to limit excessive angiogenic sprouting (Siekmann and Lawson, 2007) . Notch signalling inhibits expression of VEGF receptors in neighbouring stalk cells (Lobov et al., 2007) , thereby limiting the ability of these cells to respond to VEGF and controlling the number of tip cells per sprout. Flt4 is expressed in angiogenic tip cells (Gore et al., 2011; Shin et al., 2016) and hypersprouting of arteries induced by knockdown of dll4 can be rescued by inhibition of Vegfc-Flt4 signalling (Hogan et al., 2009b; Villefranc et al., 2013) . Thus, the interplay between VEGF and Dll4/Notch signalling dynamically controls behaviour of angiogenic sprouts within developing vascular networks, reviewed in (Blanco and Gerhardt, 2013) .
The forkhead family of transcription factors possess a highly conserved forkhead DNA binding domain (Kaufmann and Knochel, 1996; Lai et al., 1993) and more than 40 forkhead box (Fox) proteins have been identified in mammals (Ivanov et al., 2013) . Members of the C class of Fox proteins, FOXC1 and FOXC2 have been implicated in vascular development (Kume, 2009 ) and mutations in FOXC1 have been described in cerebral small vessel disease which can lead to stroke (French et al., 2014) . FOXC1 is also mutated in Axenfeld-Rieger syndrome which causes craniofacial defects including iris hypoplasia (Smith et al., 2000) .
Mutations in FOXC2 cause lymphoedema-distichiasis syndrome and result in primary lymphoedema (Mellor et al., 2011) . Murine Foxc1 or Foxc2 mutants exhibit pre-or perinatal lethality with variable cardiovascular and skeletal defects (Iida et al., 1997; Smith et al., 2000; Topczewska et al., 2001a; Winnier et al., 1997; Winnier et al., 1999) . Foxc1; Foxc2 double mutant mice exhibit similar developmental abnormalities to Foxc1 single mutants but with increased severity and abnormal arteriovenous specification, indicating redundant functions between these genes (Seo et al., 2006; Topczewska et al., 2001a) . Murine Foxc1; Foxc2 double mutants die by E9.5 preventing detailed analysis of angiogenesis, however some Foxc1+/-; Foxc2-/-embryos survive until E12.5 and exhibit arteriovenous malformations (Seo et al., 2006) .
In teleosts, Foxc2 has been lost, while Foxc1 has undergone duplication to generate the paralagous genes foxc1a and foxc1b (Topczewska et al., 2001b ) and this study. Functional studies of foxc1a and foxc1b during vascular development have relied on gene knockdown and mutant analysis has been lacking. Knockdown of foxc1a and foxc1b by morpholino has been reported to induce cerebral haemorrhage and circulation defects (De Val et al., 2008; Skarie and Link, 2009 ) and this was suggested to arise from arteriovenous malformations and reduced vascular basement integrity (Skarie and Link, 2009 ). However, reported disruption of angiogenesis induced by knockdown of foxc1a and foxc1b are inconsistent between studies (De Val et al., 2008; Skarie and Link, 2009) . Foxc transcription factors can directly activate the Dll4 and Hey2 promoter in cultured ECs, indicating these genes function to promote Notch signalling (Hayashi and Kume, 2008; Seo et al., 2006) . In zebrafish, foxc1a synergises with Notch signalling during kidney development and Foxc1a can activate Notch targets in vitro (O'Brien et al., 2011) , however whether foxc1a/b act upstream of Notch during zebrafish vascular development is not known. Foxc2 combinatorically activates EC genes in partnership with Etv2 in Xenopus embryos and foxc1a/b knockdown in zebrafish reduced angiogenesis within the developing trunk (De Val et al., 2008) . In addition, knockdown of foxc1a/b in zebrafish has been reported to reduce Etv2 promoter activity, suggesting these genes also function upstream of Etv2 (Veldman and Lin, 2012) . Several recent studies using foxc1a mutants have indicated a requirement for foxc1a during neural circuit development (Banerjee et al., 2015) in addition to anterior somite formation (Hsu et al., 2015; Li et al., 2015) which is consistent with previous knockdown studies (Topczewska et al., 2001b) .
However, mutant analysis of foxc1a during vascular development and investigation of potential genetic interaction between foxc1a and foxc1b during this process remain unaddressed.
We have generated novel zebrafish foxc1a and foxc1b mutants and characterised the function of these transcription factors during angiogenesis. foxc1a mutants display abnormal cranial angiogenesis including delayed formation of primordial hindbrain channels and almost total loss of central arteries within the developing hindbrain, whereas foxc1b mutants are morphologically normal. By contrast, foxc1a; foxc1b double mutants exhibit ectopic sprouting of segmental arteries within the developing trunk and reduced segmental vein formation, in addition to abnormal cranial vessel formation observed in foxc1a single mutants.
We find that foxc1a promotes venous expression of VEGF receptors including vegfr3/flt4 and vegfr4/kdrl, thereby promoting venous angiogenesis, whilst foxc1a and foxc1b genetically interact to limit angiogenesis from arteries by suppressing Vegfc/Flt4 signalling via induction of Dll4/Notch signalling. Our data indicates foxc1a and foxc1b play compensatory and context-dependent roles to co-ordinate angiogenesis from arteries and veins via differential regulation of pro-and anti-angiogenic signalling.
Results

foxc1a mutants display multiple vascular abnormalities while foxc1b mutants are morphologically normal
Mammals have two Foxc genes, Foxc1 and Foxc2 (Fig. S1, S2 ), whereas teleost lineages have no identifiable foxc2 ortholog (Fig. S2 ) but possess two paralogous Foxc1 orthologues, foxc1a and foxc1b (Topczewska et al., 2001b) . To investigate the specific functions of foxc1a and foxc1b during vascular development, we generated zebrafish mutants using genome editing (see methods). Wild type foxc1a and foxc1b comprise single exon genes, which encode proteins containing 476 and 433 amino acids respectively (Fig. 1A, B) (Topczewska et al., 2001b) . The foxc1a sh356 mutant allele contains a 4bp insertion, generating a protein which is predicted to retain the first 56 amino acids of wild type Foxc1a before shifting frame and truncating following 14 incorrect amino acids ( Fig. 1A ; Fig. S3 A, B) . The foxc1b sh408 mutant allele contains a 13bp deletion, which is predicted to shift frame after the first 58 amino acids and prematurely truncate the protein following 10 incorrect amino acids ( Fig. 1B Previous studies have demonstrated functions for foxc1a during somite formation and patterning (Hsu et al., 2015; Li et al., 2015; Topczewska et al., 2001b) and abnormal somite formation is known to influence the migratory path of ECs (Shaw et al., 2006) . We therefore examined somite morphology in our foxc1 mutants and identified that while somite morphology was normal in foxc1b mutants consistent with normal ISV patterning in these ( Fig. S4B arrowheads), the formation of somites 1-4 was abnormal in foxc1a mutants ( 
foxc1a is required for central artery formation
Since blood circulation was absent throughout the trunk in the majority of foxc1a and foxc1a; foxc1b double mutants but cranial circulation was retained in some embryos, we first examined the hindbrain region where these two circulatory loops interconnect, using confocal time lapse microscopy ( Fig. S5 ). foxc1a mutant embryos displayed delayed angioblast migration during the formation of primordial hindbrain channels (PHBC) ( foxc1a mutants, confirming that loss of these vessels was due to mutation of foxc1a.
foxc1a mutants display reduced expression of genes required for normal formation of
PHBCs and CtAs
Delayed PHBC formation in foxc1a mutants (Fig. 2, S5 ) is very similar to that induced by vegfr3/flt4 and vegfc loss of function (Covassin et al., 2006; Hogan et al., 2009b; Shin et al., 2016; Villefranc et al., 2013) . By contrast, while Vegfc signalling through Flt4 is dispensable for CtA formation (Hogan et al., 2009b; Le Guen et al., 2014) , the VEGF receptor kdrl is required for CtA sprouting from the PHBC but is dispensable for PHBC formation (Bussmann et al., 2011; Habeck et al., 2002) . Consistent with this, expression of flt4 was reduced within cranial vessels including the PHBC (Fig. 3A , B black arrowheads) and CCV (Fig. 3A , red arrowheads, B, red asterisks). Furthermore, persistent reductions in flt4 expression were observed in the PHBC in foxc1a mutants after it had formed (Fig. 3C, D black arrowheads). kdrl expression was also substantially reduced in cranial vessels including the PHBC (Fig. 3E , F black arrowheads) and CCV ( Fig. 3E red arrowheads, F red asterisks)
in foxc1a mutants, which would explain lack of CtAs. In addition, expression of sox7, a transcription factor required for formation of central arteries (Hermkens et al., 2015) , was substantially reduced in cranial vessels including the PHBC ( Previous studies have reported expression of foxc1a within cranial mesenchyme and hyaloid vasculature (Skarie and Link, 2009 ). Since foxc1a mutants lacked central arteries ( Fig. 2) and expression of genes which co-ordinate their formation (Fig. 3) , we examined whether foxc1a was expressed within PHBCs using fluorescent in situ hybridisation and immunocytochemistry (Fig. S7) . foxc1a was expressed widely throughout cranial mesenchyme and the developing eye (Fig. S7A , A") as previously reported (Skarie and Link, 2009 and foxc1b interact genetically and negatively regulate angiogenesis in this region. Ectopic ISV sprouting in foxc1a; foxc1b double mutants was observed as early as 28hpf ( Fig. 4A-C) and since secondary angiogenesis originating from the posterior cardinal vein (PCV) does not begin until 32hpf (Yaniv et al., 2006) (Fig. S8A-C) , however foxc1b expression was excluded from trunk ECs at this stage ( Fig. S8D-F ).
Since arterial angiogenesis was increased in foxc1a; foxc1b double mutants while cranial vein formation was inhibited in both foxc1a single and foxc1a; foxc1b double mutants, we examined segmental vein (SeV) sprouting in these embryos (Fig. S9) . Quantification of the relative distribution of SeAs and SeVs in foxc1a and foxc1a; foxc1b double mutants using a Tg(fli1a:EGFP;flt1:RFP) background, revealed a 50% reduction in SeV frequency in both mutants (Fig S9A) . Since flt4 expression was reduced in cranial veins of foxc1a mutants ( VEGF signalling is essential for SeA formation in zebrafish (Bahary et al., 2007; Covassin et al., 2006; Habeck et al., 2002; Lawson et al., 2003; Nasevicius et al., 2000; Rossi et al., 2016; Shin et al., 2016; Weinstein and Lawson, 2002) and VEGF receptor expression was reduced in trunk ( Fig. S9) and cranial ( Fig. 3 ) vessels of foxc1a mutants. We therefore examined expression of additional components of VEGF signalling in foxc1a and foxc1a; foxc1b double mutants (Fig. 5) . Vegfa is the major VEGF isoform which promotes SeA formation in zebrafish and vegfaa expression was normal in foxc1a and foxc1a; foxc1b double mutants ( Fig. 5A-C) . However, kdrl expression was moderately reduced in the DA (Fig. 5D-F , red arrowheads) and SeAs ( Fig. 5D-F , black arrowheads) of foxc1a and foxc1a; foxc1b double mutants, in keeping with our observations of reduced kdrl expression within cranial vessels of foxc1a mutants (Fig. 3E, F) . By contrast, flt4, which is preferentially expressed in venous ECs, was normal within the PCV (Fig. 5 G-I , blue arrowheads), but its expression was not downregulated within SeAs in foxc1a; foxc1b double mutants by 24hpf in comparison to foxc1a mutants (Fig. 5G-I, black arrowheads) . Expression of the soluble VEGF decoy receptor, sflt1 was reduced in the DA (Fig. 5J -K, red arrowheads) and SeAs ( Fig. 5J -K, black arrowheads) of foxc1a mutants and more substantially reduced in foxc1a; foxc1b double mutants (Fig. 5L arrowheads) . Given that Kdrl promotes SeA formation (Covassin et al., 2006; Habeck et al., 2002) and its expression was not significantly altered between foxc1a and foxc1a; foxc1b double mutants (Fig. 5E, F) , we reasoned that the moderate reduction in kdrl expression in both mutants compared to wild type sibs was unlikely to account for the ectopic SeA sprouting observed in foxc1a; foxc1b double mutants. By contrast, sflt1 expression was substantially reduced in foxc1a; foxc1b double mutants compared to foxc1a mutants ( Fig. 5N , O arrowheads) and this receptor has been shown to antagonise sprouting angiogenesis (Krueger et al., 2011; Zygmunt et al., 2011) . We therefore overexpressed sflt1 in foxc1a; foxc1b double mutants and quantified frequency of ectopic SeA sprouts (Fig. S10) .
Frequency of ectopic SeAs were comparable in foxc1a; foxc1b double mutants in the presence or absence of sflt1 overexpression (Fig. S10A-D , arrowheads) indicating reduced sflt1 expression did not account for ectopic sprout formation in double mutants (Fig. S10E ).
These data are consistent with recent studies which have demonstrated that sflt1 limits sprouting from veins, but not arteries (Matsuoka et al., 2016; Wild et al., 2017 enhancer (Sacilotto et al., 2013) was substantially reduced in developing arteries of foxc1a mutants and was further reduced in foxc1a; foxc1b double mutant SeAs (Fig. 6A-C , black arrowheads) and DA ( Fig. 6A-C, red arrowheads) . Furthermore, expression of dll4 (Fig. 6D-F ) and the Notch target hey2/gridlock (Fig. 6G-I ) were substantially reduced in foxc1a; foxc1b double mutant SeAs (Fig. 6D-I , black arrowheads) and DA ( Fig. 6D-I (Fig. 6P-T) . We observed reduced formation of parachordal lymphangioblasts in vegfc morphants (Fig. 6R , S, asterisks) as previously described (Hogan et al., 2009a; Hogan et al., 2009b) indicating Vegfc function was inhibited.
The frequency of ectopic SeAs in foxc1a; foxc1b double mutants was significantly reduced by vegfc knockdown in comparison to control double mutants (Fig. 6Q , S, T, arrowheads).
Collectively, our data indicates foxc1a and foxc1b antagonise angiogenesis from arteries by promoting Dll4/Notch-mediated repression of Vegfc/Flt4 signalling. Conversely, foxc1a also promotes venous angiogenesis by positively regulating VEGF receptor expression in veins (Fig. 7) . Thus, foxc1a and foxc1b act in concert to balance angiogenesis from arteries and veins by promoting context dependent expression of both pro-and anti-angiogenic genes during development.
Discussion
Here we report a detailed genetic analysis of foxc1a and foxc1b during zebrafish vascular development. Zebrafish foxc1a mutants display vascular defects localised to the cranial vasculature, foxc1a; foxc1b double mutants display additional defects in trunk vasculature, while foxc1b mutant vasculature is normal. This indicates foxc1a can fully compensate for loss of foxc1b during blood vessel development in zebrafish, whereas foxc1b can only partially compensate for loss of foxc1a during formation of trunk vasculature. Furthermore, a single copy of foxc1a is compatible with normal embryonic development following loss of both foxc1b alleles.
Mammals have 2 Foxc genes, Foxc1 and Foxc2, however, Foxc2 has been lost in teleost lineages and Foxc1 has undergone duplication (Fig. S1, S2 ). Structural analysis suggests FOXC proteins have the same binding specificity (van Dongen et al., 2000) and are likely to regulate the same downstream targets when co-expressed (Hayashi and Kume, 2008) . It therefore seems surprising that foxc1a and foxc1b mutants have such different phenotypes given that the forkhead DNA binding domain is 97% identical at the protein level in Foxc1a and Foxc1b (Topczewska et al., 2001b) and is probable these transcription factors have highly similar or identical targets. Our data are consistent with this, since we observed greater reductions in expression of the Foxc targets dll4 and hey2 (Hayashi and Kume, 2008) in foxc1a; foxc1b double mutants than in foxc1a mutants. The morphological difference between foxc1a and foxc1b mutants are therefore not likely to be explained by differential regulation of target genes, but by differential expression of foxc1a and foxc1b during development, for example, foxc1a is expressed in zebrafish ECs whereas foxc1b is excluded from these ( Fig. S7, S8 ).
Mutation of FOXC1 has been proposed to induce human pathologies including cerebral small vessel disease (CSVD) (French et al., 2014) . In mice, Foxc1 is expressed in both pericytes and ECs (Kume et al., 2001; Siegenthaler et al., 2013) . Conditional knockout of Foxc1 in mouse pericytes induces cerebral haemorrhage and as such Foxc1 function in pericytes has been proposed to maintain integrity of the blood brain barrier in mammals (Siegenthaler et al., 2013) . Constitutive Foxc1 knockout mice exhibit similar defects to pericyte-specific Foxc1 knockout mice but with much greater phenotypic severity (Kume et al., 1998; Siegenthaler et al., 2013) . Interestingly, EC specific inactivation of Foxc1 in mice does not recapitulate cerebral vascular defects displayed in either pericyte-specific Foxc1 knockout or constitutive Foxc1 KO mice (Mishra et al., 2016) , indicating Foxc1 functions non-cell autonomously to promote cerebral blood vessel formation in the mouse. In zebrafish, combined knockdown of foxc1a and foxc1b by morpholino has been reported to induce cerebral haemorrhage in embryos (French et al., 2014; Skarie and Link, 2009 ) and this was proposed to occur via reduced vascular basement membrane integrity (Skarie and Link, 2009) or inhibition of foxc1a/foxc1b-mediated induction of Pdgf signalling in pericytes (French et al., 2014 ). While we also observe reduced expression of pdgfrb in foxc1a mutants (not shown) and find both foxc1a and foxc1b are expressed perivascularly in the zebrafish brain prior to mural cell emergence (Fig. S7) , we have not observed cerebral haemorrhage in either foxc1a or foxc1a; foxc1b double mutant embryos, even in those which retain anterior circulation. These differences could be due to incomplete gene knockdown in morphants, off target effects of morpholinos, or potential compensatory mechanisms which promote vascular integrity in our mutants. However, recent studies in zebrafish have demonstrated that while pdgfrb is essential for recruitment of mural cells to cranial vessels including CtAs, mural cells are recruited to cranial vessels such as CtAs only after they have formed and cranial angiogenesis is normal in pdgfrb mutants which lack mural cells (Ando et al., 2016) . Therefore, since foxc1a mutants display reduced cranial angiogenesis, foxc1a-mediated induction of pdgfrb expression is unlikely to contribute to cranial angiogenesis in zebrafish.
Deletion of Foxc1 in mouse neural crest-derived cells reproduces cerebrovascular phenotypes of global mouse Foxc1 mutants (Mishra et al., 2016) , indicating its function in this tissue is essential to co-ordinate cranial angiogenesis, however, neural crest cell specification is dispensable for cranial angiogenesis in zebrafish (Ando et al., 2016; Wang et al., 2014) . This indicates substantial divergence between Foxc1-mediated regulation of vascular development between mouse and zebrafish and suggests that in contrast to mouse, endothelial expression of foxc1a is important during cranial angiogenesis in zebrafish. Consistent with this, foxc1a is expressed in cranial vessels (Fig. S7) , which are abnormal in foxc1a mutants while foxc1b is excluded from ECs ( Fig. S7 ) and foxc1b expression is not induced in ECs in the absence of foxc1a (not shown). Our analysis of foxc1a and foxc1b mutants suggests foxc1a is a master regulator of cranial angiogenesis which functions in ECs to promote angiogenesis from cranial veins by inducing VEGF receptor expression and other pro-angiogenic factors including sox7. By contrast, foxc1a is dispensable for angiogenesis from arteries, however, loss of both foxc1a and foxc1b induces ectopic angiogenesis from arteries within the developing trunk through reduced Dll4/Notch signalling (Fig. 6, 7) . Since foxc1b is not expressed in ECs within the developing zebrafish trunk, but is expressed in neighbouring somitic tissues including sclerotome (Fig. S8) (Topczewska et al., 2001b) , this suggests foxc1b induces Dll4/Notch signalling in ECs non-cell autonomously.
In mice, non-cell autonomous anti-angiogenic functions for Foxc1 have been described, for example, Foxc1 expression in neural crest suppresses corneal angiogenesis via a mechanism which antagonises EC response to VEGF signalling (Seo et al., 2012) . Counterintuitively, increased angiogenesis induced by Foxc1 KO in neural crest correlated with increased corneal expression of sVegfr1/sFlt1, suggesting Foxc1 regulates competing pro-and antiangiogenic mechanisms (Koo and Kume, 2013; Seo et al., 2012) . Similarly in zebrafish, we find context-dependent functions of foxc1a and foxc1b in suppressing angiogenesis from arteries, while promoting angiogenesis from veins. In contrast to the mouse cornea where Foxc1 expression in neural crest cells suppresses sFlt1 (Seo et al., 2012) , foxc1a and foxc1b promote expression of anti-angiogenic sflt1 within the DA in zebrafish (Fig. 5K, L) . sflt1 has recently been demonstrated to antagonise sprouting of veins in zebrafish (Matsuoka et al., 2016; Wild et al., 2017) , and induction of sflt1 may therefore represent an additional mechanism by which Foxc1 limits venous angiogenesis within the developing trunk, for example, to balance its pro-angiogenic effects on SeV sprouting from the PCV (Fig. S9) .
Interestingly, we observed reduced expression of kdrl in SeAs of foxc1a and foxc1a; foxc1b double mutants, which is consistent with studies which demonstrate Foxc proteins function co-operatively with ETS transcription factors to induce endothelial gene expression and directly bind enhancers within vegfr2/kdr (De Val et al., 2008) . However, these studies also reported reduced sprouting of intersegmental vessels (ISVs) at 24hpf following combined knockdown of foxc1a/b by morpholino (De Val et al., 2008) , whereas our mutant analysis showed that despite reductions in kdrl expression following loss of foxc1a and foxc1b, SeA sprouting was not reduced, but enhanced via a Dll4/Notch dependent mechanism (Fig. 6 ).
However, since inhibition of ISV formation was observed at very high doses of morpholino, off target effects cannot be excluded as a potential cause for these differences (De Val et al., 2008) . Collectively, our data suggests that foxc1a and foxc1b control angiogenesis 
Materials and Methods
Zebrafish strains
All zebrafish were maintained according to institutional and national ethical and animal welfare guidelines. The following zebrafish lines were employed: Tg(fli1a:EGFP) y1 (Lawson and Weinstein, 2002) , Tg hu5333 (Bussmann et al., 2010), Tg(kdrl:HRASmCherry-CAAX) s916 (Hogan et al., 2009a) , Tg(flk1:EGFP-NLS) zf109 (Zygmunt et al., 2011), Tg(dll4in3:GFP) lcr1 (Sacilotto et al., 2013), Tg (hs:gal4); Tg(5xUAS-E1b:6xMYC-notch1a ) (Scheer and Campos-Ortega, 1999) , foxc1a sh356 and foxc1b sh408 .
Bioinformatic analysis of foxc1a and foxc1b synteny
Orthology information for the gene of interest, plus the nearest neighbouring genes were mined from the Ensembl API (accessed October 2015). If no known orthologous gene was present in a species of interest then BLAST was used to identify the closest three genome hits
with an e-value less than 1E-10. If a BLAST hit was not within a known gene model then the likelihood of an unannotated gene being present was manually analysed using EST, RNASeq sequences and GenScan data. However, in the majority of cases an Ensembl gene was identified and therefore orthology was determined based on synteny.
Generation, selection and genotyping of foxc1a and foxc1b mutant alleles foxc1a sh356 allele
Zinc finger nucleases (ZFN) specific for foxc1a (ENSDARG00000091481) were generated via context dependent assembly (Sander et al., 2011) targeting the following sequence 5'-gTACCCCGCCAGCATGGCGAGGGCa-3'. For the left and right subunits, zinc fingers were added by PCR using pCS2ta3LFok1 and pCS2ta3RFok1 respectively (Ben et al., 2011) as templates, and primers listed in Supplementary Table 1 . PCR products were digested with AgeI and self-ligated to generate pCS2foxc1a5-1L and pCS2foxc1a5-1R. Capped mRNA from each plasmid was generated by in vitro transcription and 800-1600pg mRNA injected per embryo such that embryos had an appropriate 30% rate of deformity at 24hpf. To detect potential somatic mutations, genomic DNA extracted from non-deformed embryos was amplified by PCR using foxc1a5-1F and foxc1a5-1R genotyping primers (Supplementary Table 1 ). Roche Titanium 454 amplicon sequencing identified 90/871 (10%) amplicon molecules included insertions or deletions at the target site. G0 adults derived from embryos injected with ZFN capped mRNA were in-crossed and G1 progeny genotyped by PCR. The sh356 allele contains a 4bp insertion which generates a unique NsiI restriction site ( Figure   S3 ). Genotyping was performed as described previously (Wilkinson et al., 2013) incrossed and genotyped to confirm the presence of the SH408 allele, which consists of a 13bp deletion which destroys a unique NdeI restriction site ( Figure S3 ). Following digestion with NdeI, WT foxc1b allele generates fragment sizes of 130bp and 98bp, whereas the foxc1b sh408 allele generates an undigested 215bp fragment.
Plasmid construction and full length mRNA synthesis foxc1a coding sequence from Danio rerio foxc1a cDNA clone IMAGE: 6789584 was cloned into pCS2+ using EcoRI and XhoI. pCS2-sflt1 was kindly provided by Ferdinand le Noble (Krueger et al., 2011) . Capped mRNA was generated using mMessage Machine SP6 Kit (Ambion).
In situ probes
foxc1a and foxc1b in situ probes were generated by PCR amplification using primer sets foxc1aT3F/T7R, foxc1bT3F/T7R and IMAGE: 6789584 (foxc1a) or IMAGE: 5601888 (foxc1b) as templates. PCR products were subsequently transcribed with RNA polymerase.
xirp2a was kindly provided by Salim Seyfried (Otten et al., 2012) .
Whole-mount in situ hybridisation
Whole mount colorimetric and fluorescent in situ hybridisation was performed as previously described (Wilkinson et al., 2012 ) (Thambyrajah et al., 2016) . GFP expression was detected using Anti-GFP antibody (TP401; amsbio; 1:1000) alongside anti-DIG-POD antibody.
Embryos were incubated with AlexaFluor-488 secondary antibody (Invitrogen; 1:500) and imaged.
Microinjection 0.4ng vegfc ATG morpholino 5′-GAAAATCCAAATAAGTGCATTTTAG-3′ (Genetools) (Hogan et al., 2009a) or standard control morpholino (5'-CCTCTTACCTCAGTTACAATTTATA-3') (Genetools) (Lee et al., 2002) were injected into one cell stage embryos.
Heat shock induction of UAS-NICD
Heat shock was performed at 18s by incubating embryos with pre-warmed E3 at 37°C for 30mins. Embryos were maintained at 28.5°C following heatshock.
Microscopy and image processing
Confocal images were collected using Perkin Elmer Ultraview Vox microscope and lightsheet images were performed using a ZEISS Lightsheet Z.1 microscope. Spinning disk confocal images were analysed using Volocity (PerkinElmer) and Lightsheet images were analysed with ZEN software. Images of embryos following in situ hybridisation was taken using a Leica M165FC and Leica DFC and imaged using Leica Application Suite software (LAS v4.3.0) . Image analysis was performed using ImageJ.
Statistical Analysis
All statistical analysis used two-tailed tests and was performed using GraphPad Prism 7. All error bars display the mean and standard deviation. P values, unless exact value is listed, are as follows: *=<0.05, **=<0.01, ***=<0.001, ****=<0.0001. 
